Etropal AD operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Etropal AD with three other
medical equipment manufacturers in Europe:
sales of 4.85 million Euros [US$5.81 million]
(3.38 million Euros [US$4.05 million]
Safe Orthopaedics SA
based in FRANCE
(3.84 million Euros [US$4.60 million]
During the year ended December of 2020, sales at
Etropal AD were 7.46 million Bulgarian Levas (US$4.57 million).
increase of 9.5%
versus 2019, when the company's sales were 6.81 million Bulgarian Levas.
Despite this increase, sales are still
below the level achieved in 2018, when Etropal AD
reported sales of 8.30 million Bulgarian Levas.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Etropal AD had sales
of 7.91 million Bulgarian Levas.